

While CVS does not participate in this market directly, building any additional services into the home in our view would be a positive step, even if it feels like there is more urgency on the primary care side." "SGFY used an over-arching tech platform that both allows for optimal efficiency for its clinicians but also to ensure the most appropriate types of evaluations in the home. "Since the CVS investor day in December of last year, investors have been waiting for details on how the company plans to deploy capital in order to improve its care delivery model," says BofA Global Research analyst Michael Cherny, who has a Buy rating on CVS.

CVS plans to submit an offer for SGFY in the coming week, the article indicates, citing people familiar with the matter.
